Vanguard Asset Management
OLMA icon

Vanguard Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Vanguard Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483K Buy
38,594
+13,796
+56% +$185K ﹤0.01% 2201
2026
Q1 		$370K Buy
+24,798
New +$552K ﹤0.01% 2227

Other funds holding OLMA

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Asset Management's OLMA Position: Q2 2026 in Review

Vanguard Asset Management increased its Olema Pharmaceuticals (OLMA) stake by 56% in Q2 2026, buying an estimated $185K and bringing the position to 38,594 shares worth $483K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Vanguard Asset Management first reported a position in OLMA in Q1 2026 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Vanguard Asset Management held 38,594 shares of Olema Pharmaceuticals worth $483K as of Q2 2026.
  • Vanguard Asset Management bought 13,796 Olema Pharmaceuticals shares in Q2 2026, an estimated $185K.
  • Olema Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #2201 holding.
  • Vanguard Asset Management first reported a position in Olema Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 167 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.